Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.

Richard B LiptonPranav GandhiJonathan StokesMary Lynn CalaChristopher J EvansNaomi KnobleHeather L GelhornDennis RevickiHema N ViswanathanDavid W Dodick

Published in: Headache (2021)

The AIM-D is a content valid and psychometrically sound measure designed to evaluate activity impairment and is suitable for use in clinical trials of preventive treatments for EM or CM.

Keyphrases

patient reported outcomes
clinical trial
randomized controlled trial
open label
drug induced